BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 16978953)

  • 1. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.
    Cocilovo C; Boolbol SK; Valdes E; Feldman S
    Am J Surg; 2006 Oct; 192(4):478-80. PubMed ID: 16978953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
    Spillane AJ; Brennan ME
    Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary Dissection with Access Minimized (ADAM): a new technique for lymph node dissection in conservative surgery for breast cancer.
    Paepke S; Schwarz-Boeger U; Kiechle M; Jacobs VR
    Int J Fertil Womens Med; 2003; 48(5):232-7. PubMed ID: 14626380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy in elderly breast cancer patients.
    Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U
    Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of use of a clinicopathological score to select patients for the type of axillary surgery.
    Pinkney TD; Nightingale P; Carmichael AR
    Eur J Surg Oncol; 2007 Mar; 33(2):153-6. PubMed ID: 17097850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.
    Roumen RM; Kuijt GP; Liem IH; van Beek MW
    Br J Surg; 2001 Dec; 88(12):1639-43. PubMed ID: 11736979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of the sentinel lymph node procedure in patients with large size breast cancer.
    Lelievre L; Houvenaeghel G; Buttarelli M; Brenot-Rossi I; Huiart L; Tallet A; Tarpin C; Jacquemier J
    Ann Surg Oncol; 2007 Feb; 14(2):621-6. PubMed ID: 17103062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of sentinel lymph node biopsy through an inframammary incision for a nipple-sparing mastectomy.
    Kiluk JV; Santillan AA; Kaur P; Laronga C; Meade T; Ramos D; Cox CE
    Ann Surg Oncol; 2008 Dec; 15(12):3402-6. PubMed ID: 18820974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminishing morbidity with the increased use of sentinel node biopsy in breast carcinoma.
    Bafford A; Gadd M; Gu X; Lipsitz S; Golshan M
    Am J Surg; 2010 Sep; 200(3):374-7. PubMed ID: 20409517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma.
    Dale PS; Williams JT
    Am Surg; 1998 Jan; 64(1):28-31; discussion 32. PubMed ID: 9457034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
    Golshan M; Martin WJ; Dowlatshahi K
    Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
    Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
    Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.
    Wilke LG; McCall LM; Posther KE; Whitworth PW; Reintgen DS; Leitch AM; Gabram SG; Lucci A; Cox CE; Hunt KK; Herndon JE; Giuliano AE
    Ann Surg Oncol; 2006 Apr; 13(4):491-500. PubMed ID: 16514477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients.
    Langer I; Kocher T; Guller U; Torhorst J; Oertli D; Harder F; Zuber M
    Breast Cancer Res Treat; 2005 Mar; 90(1):85-91. PubMed ID: 15770531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.